Eye CareNCT07070843
Effects of Two Different Eye Care Practices on Eye Complications in Mechanically Ventilated Intensive Care Patients
A study testing Intervention Group 1: Eye Care Using an Eye Care Kit, Intervention Group 2: Eye Care According to an Eye Care Protocol and Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit in people with Eye Care and Nursing Care, run by Istanbul Saglik Bilimleri University at 1 site in Turkey (Türkiye).
Trial summary
This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. Read more about this study
- Who is it for?
- Ages 18 days and older
- Conditions the study is for
- Eye Care, Nursing Care, Intensive Care Unit
- What is being tested?
- Intervention Group 1: Eye Care Using an Eye Care Kit, Intervention Group 2: Eye Care According to an Eye Care Protocol and Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 156 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2025to Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 days and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Age 18 years or older
- Receiving mechanical ventilation
- Glasgow Coma Scale (GCS) score < 12
- At least 24 hours have passed since ICU admission
- Baseline Schirmer test result indicating tear production > 5 mm prior to study inclusion
Who cannot join
- Diagnosed with brain death
- Presence of facial or ocular trauma
- Patients with head trauma
- Patients who have undergone brain surgery
- Patients diagnosed with an eye infection or chemosis
- Withdrawal Criteria:
- Patient's death during the study period
- Extubation of the patient before completion of the care period
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
University of Health Sciences (Sağlık Bilimleri Üniversitesi)
Istanbul, Istanbul, 34668
About this study
This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
- Control Group: Standard Eye Care
- Intervention Group 1: Eye Care with Eye Care Kit
- Intervention Group 2: Eye Care According to Eye Care Protocol
- Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care.
Read more
H2: Eye care provided using an eye care kit is more effective in preventing the development of ocular complications compared to standard eye care.
H3: The combined use of an eye care kit and a care protocol is more effective in preventing the development of ocular complications compared to using the care protocol alone.
H4: The use of an eye care kit is more effective in preventing the development of ocular complications compared to the use of a care protocol.
Read the detailed description
Study Design and Methodology
In this study, patients receiving mechanical ventilation support in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
- Control Group: Standard Eye Care Group There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze.
- Intervention Group 1: Eye Care Using an Eye Care Kit Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit.
- Intervention Group 2: Eye Care According to an Eye Care Protocol
- All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol.
- Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol.
- Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary.
- In cases of incomplete eyelid closure, eyes will be covered upon physician notification.
- Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form.
- Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit
- ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care.
- Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol.
- Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol, including:
- In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge.
Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form.
Evaluation and Analysis During the study period, all patient groups will be assessed at specific intervals for ocular complications (conjunctival edema, eye infections, and dry eye). The effectiveness of the interventions will be measured accordingly. Clinical observation, the Schirmer test, and necessary laboratory/imaging methods will be used for the assessment of ocular complications.
Inter-group differences will be statistically analyzed based on pre-defined dependent variables. The study aims to evaluate whether the use of the eye care protocol and/or the eye care kit provides superior outcomes compared to standard care in the prevention of complications.
The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for all group will be collected, and the administration and documentation of eye care will be monitored.
Study Variables Dependent Variables: Conjunctival edema, eye infections, and dry eye observed in ICU patients.
Independent Variables: Age, gender, diagnosis, comorbidities, Glasgow Coma Scale score, use and type of sedation, use and type of muscle relaxants, use and type of antibiotics, duration of mechanical ventilation, ventilator mode, ambient humidity level, blinking frequency, eyelid closure level, albumin levels, Schirmer test results, and use of the eye care kit.
Sample Size The study population will consist of all patients who are connected to mechanical ventilators for diagnosis, treatment, or follow-up and are admitted to the Anesthesia and Reanimation Intensive Care Units of Kartal Dr. Lutfi Kırdar City Hospital, which operates under the Istanbul Provincial Health Directorate.
To determine the required sample size, a power analysis was conducted using the G*Power software (version 3.1.9.4). The power of the study is expressed as 1-β (where β represents the probability of a Type II error). Based on the Chi-square test for independent groups: Goodness-of-fit tests - Contingency tables, and assuming an effect size of d = 0.58 for the secretion variable, the analysis indicated that a minimum of 39 participants per group is required.
Randomization Method After identifying patients who meet the inclusion criteria, they will be randomly assigned to the intervention and control groups. The randomization process will be conducted using a computer-based random number generator (e.g., Excel's RAND() function or tools such as random.org). This approach ensures independence and balance between groups.
Data Collection Tools Data will be collected using the Patient Identification Form, the Glasgow Coma Scale, the "Eye Care Protocol" developed by Ayfer Hiçerimez in 2024 for intensive care unit (ICU) patients, and the Schirmer Test to assess ocular dryness. Eye care interventions will be implemented based on the "Eye Care Kit Application Procedure" developed by the researcher.
- Patient Identification Form
- This form includes descriptive and clinical characteristics of the patient, such as: Age, gender, primary diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, serum albumin level.
- It also includes ocular risk factors, such as: Absence or reduction of blink reflex, ocular exposure due to incomplete eyelid closure, requirement for invasive mechanical ventilation, positive end-expiratory pressure (PEEP) level, endotracheal suctioning, tightly secured endotracheal tube, use of sedation, use of specific medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and overall patient positioning, presence of respiratory tract infections.
- Eye Care Protocol The Eye Care Protocol, developed by Ayfer Hiçerimez in 2024 for ICU patients, was designed to evaluate the effectiveness of systematic eye care and includes comprehensive assessment and care of both eyes.
- The first section of the protocol includes the patient's demographic and clinical characteristics, such as: age, gender, diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, and serum albumin levels.
- The second section addresses ocular risk factors, including: absence or reduction of the blink reflex, ocular exposure due to incomplete eyelid closure, need for invasive mechanical ventilation, level of positive end-expiratory pressure (PEEP), endotracheal suctioning, tightly secured endotracheal tube, use of sedation, use of medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and general patient positioning, and the presence of respiratory tract infections.
- The third section focuses on eye care management procedures, including:
- Hand hygiene
- Elevating the head of the bed to 30-45 degrees unless contraindicated
- Implementing infection control precautions
- Performing eye care four times daily using sterile water
- Assessing the tightness of the endotracheal tube during each eye care session
- Ensuring that the eyes of intubated patients are closed during suctioning
- Using separate sterile materials for each eye to prevent cross-infection
- Assessing and documenting ocular changes (e.g., redness, secretions, crusting at the eyelid margins, eyelash adhesion, discoloration of the conjunctiva, periorbital and conjunctival edema), and informing the ICU physician as needed
- The fourth section outlines the signs and symptoms of eye infection, including: redness, discharge, crusting of the eyelid margins, eyelash adhesion, discoloration or opacity of the cornea, and periorbital edema.
- The fifth section addresses ocular complications, specifically conjunctival edema, that may be observed in ICU patients.
- Dry Eye Monitoring Form The Schirmer Test is used to evaluate dry eye by utilizing thin filter paper strips measuring 5 mm × 30 mm. Each strip is folded at a 90° angle at one end. The bent end of the test strip is placed into the lower conjunctival sac of the eye, and left in place for 5 minutes. After 5 minutes, the strips are removed and the length of the moistened area is measured in millimeters. If the wetted portion exceeds 10 mm, tear production is considered normal. If the moist area measures less than 5 mm, it is indicative of Dry Eye Syndrome. Measurements must be taken separately for each eye.
- Eye Care Kit Application Procedure The Eye Care Kit was developed by the researchers and includes: two sterile gauze pads (one for each eye), a single-use 10 ml ampoule of distilled water, a 10 ml syringe, and an eye care pad. Two versions of the kit were prepared: one including a sterile eye occlusion pad, and one excluding it. This distinction was made to prevent unnecessary waste in patients who do not require eye occlusion. The kit content and procedure were developed with input from nine experts, and the form was revised accordingly based on their feedback.
- Standard Eye Care Record Form This form will be used to document the standard eye care provided in the intensive care unit where the study will be conducted. On each day that care is provided, the responsible nurse will complete the form, and the patient will be monitored for a total of ten days. The form was developed based on feedback from nine experts, and necessary revisions were made accordingly.
- Eye Care Monitoring Form This form will be used to collect data for both the standard eye care group and the eye care kit group.
- It includes the patient's demographic and clinical characteristics, such as: Age, gender, diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, and serum albumin level.
- It also records ocular risk factors, including: Absence or reduction of the blink reflex, ocular exposure due to incomplete eyelid closure, need for invasive mechanical ventilation, positive end-expiratory pressure (PEEP) value, endotracheal suctioning, tightly secured endotracheal tube, use of sedation, medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and overall body position, and presence of respiratory tract infections.
- The monitoring of signs and symptoms of eye infection including redness, discharge, crusting on the eyelid margins, eyelash adhesion, changes in corneal color or loss of corneal transparency, and periorbital edema,
- The assessment of conjunctival edema,
- The follow-up of dry eye.
- Conditions
- Eye Care, Nursing Care, Intensive Care Unit
- Being tested
- Control Group: Standard Eye Care Group, Intervention Group 1: Eye Care Using an Eye Care Kit, Intervention Group 2: Eye Care According to an Eye Care Protocol, Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit
- Keywords
- Critical care nursing, Eye infections, Intensive care units, Nursing care
- Medical subject headings
- Eye Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Control Group: Standard Eye Care GroupOther
There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored.
Intervention Group 1: Eye Care Using an Eye Care KitOther
Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked.
Intervention Group 2: Eye Care According to an Eye Care ProtocolOther
- All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol.
- Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol.
- Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary.
- In cases of incomplete eyelid closure, eyes will be covered upon physician notification.
- Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form.
- The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented.
Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care KitOther
- ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care.
- Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol.
- Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol.
- In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge.
- Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form.
- The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded.
| Study group | Role | What they receive |
|---|---|---|
| Control Group: Standard Eye Care Group | Experimental | There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored. Receives: Other: Control Group: Standard Eye Care Group |
| Intervention Group 1: Eye Care Using an Eye Care Kit | Experimental | Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked. Receives: Other: Intervention Group 1: Eye Care Using an Eye Care Kit |
| Intervention Group 2: Eye Care According to an Eye Care Protocol | Experimental | All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol.
Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol.
Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary.
In cases of incomplete eyelid closure, eyes will be covered upon physician notification.
Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form.
The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented. Receives: Other: Intervention Group 2: Eye Care According to an Eye Care Protocol |
| Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit | Experimental | ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care.
Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol.
Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol.
In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge.
Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form.
The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded. Receives: Other: Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit |
What is being measured
The primary outcome is the main question the study is designed to answer.
Conjunctival Edema in Critically Ill Patients
Conjunctival Edema (Chemosis): Chemosis is the edema of the conjunctiva, which is a thin, transparent membrane covering the inner surface of the eyelids and the white part of the eyes (sclera). It refers to the swelling of this membrane that lines the ocular surface.
Measured: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Ocular Infections in Critically Ill Patients
Signs and Symptoms of Ocular Infection: Redness, ocular discharge, crusting along the eyelid margins, adhesion of eyelashes (eyelashes sticking together), corneal discoloration (loss of corneal transparency), periorbital edema.
Measured: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Dry Eye in Critically Ill Patients
Dry Eye: Dry eye is a multifactorial disease of the ocular surface, defined by tear film instability and associated with symptoms including ocular discomfort, burning sensation, irritation, dryness, visual blurring, and foreign body sensation."
Measured: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2025
- Study start1 Jul 2025
- Primary completionMay 2026 (estimated)
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Eye CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 156 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul Saglik Bilimleri University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yildiz Deniz, Istanbul Saglik Bilimleri University
- Investigators
- Yildiz Deniz, Principal investigator, University of Health Sciences (Sağlık Bilimleri Üniversitesi)Besey Oren, Study director, University of Health Sciences (Sağlık Bilimleri Üniversitesi)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07070843
- Sponsor's protocol ID
- IstanbuSBU
- Status last verified
- Jan 2026
- First submitted
- 20 Jun 2025
- Last updated
- 29 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data (IPD) that underlie the results reported in publications derived from this study will be made available to qualified researchers. Shared data will include de-identified datasets and related data dictionaries.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Two Different Eye Care Practices on Eye Complications in Mechanically Ventilated Intensive Care Patients
- ClinicalTrials.gov ID
- NCT07070843
- Acronym / sponsor ID
- IstanbuSBU
- Conditions
- Eye Care, Nursing Care, Intensive Care Unit
- Keywords
- Critical care nursing, Eye infections, Intensive care units, Nursing care
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 156 participants (estimated)
- Lead sponsor
- Istanbul Saglik Bilimleri UniversityUniversity, hospital or other
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- May 2026 (estimated)
- Study completion
- Oct 2026 (estimated)
- First posted
- 17 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
- Control Group: Standard Eye Care
- Intervention Group 1: Eye Care with Eye Care Kit
- Intervention Group 2: Eye Care According to Eye Care Protocol
- Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care.
H2: Eye care provided using an eye care kit is more effective in preventing the development of ocular complications compared to standard eye care.
H3: The combined use of an eye care kit and a care protocol is more effective in preventing the development of ocular complications compared to using the care protocol alone.
H4: The use of an eye care kit is more effective in preventing the development of ocular complications compared to the use of a care protocol.
Detailed description
Study Design and Methodology
In this study, patients receiving mechanical ventilation support in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
- Control Group: Standard Eye Care Group There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze.
- Intervention Group 1: Eye Care Using an Eye Care Kit Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit.
- Intervention Group 2: Eye Care According to an Eye Care Protocol
- All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol.
- Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol.
- Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary.
- In cases of incomplete eyelid closure, eyes will be covered upon physician notification.
- Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form.
- Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit
- ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care.
- Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol.
- Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol, including:
- In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge.
Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form.
Evaluation and Analysis During the study period, all patient groups will be assessed at specific intervals for ocular complications (conjunctival edema, eye infections, and dry eye). The effectiveness of the interventions will be measured accordingly. Clinical observation, the Schirmer test, and necessary laboratory/imaging methods will be used for the assessment of ocular complications.
Inter-group differences will be statistically analyzed based on pre-defined dependent variables. The study aims to evaluate whether the use of the eye care protocol and/or the eye care kit provides superior outcomes compared to standard care in the prevention of complications.
The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for all group will be collected, and the administration and documentation of eye care will be monitored.
Study Variables Dependent Variables: Conjunctival edema, eye infections, and dry eye observed in ICU patients.
Independent Variables: Age, gender, diagnosis, comorbidities, Glasgow Coma Scale score, use and type of sedation, use and type of muscle relaxants, use and type of antibiotics, duration of mechanical ventilation, ventilator mode, ambient humidity level, blinking frequency, eyelid closure level, albumin levels, Schirmer test results, and use of the eye care kit.
Sample Size The study population will consist of all patients who are connected to mechanical ventilators for diagnosis, treatment, or follow-up and are admitted to the Anesthesia and Reanimation Intensive Care Units of Kartal Dr. Lutfi Kırdar City Hospital, which operates under the Istanbul Provincial Health Directorate.
To determine the required sample size, a power analysis was conducted using the G*Power software (version 3.1.9.4). The power of the study is expressed as 1-β (where β represents the probability of a Type II error). Based on the Chi-square test for independent groups: Goodness-of-fit tests - Contingency tables, and assuming an effect size of d = 0.58 for the secretion variable, the analysis indicated that a minimum of 39 participants per group is required.
Randomization Method After identifying patients who meet the inclusion criteria, they will be randomly assigned to the intervention and control groups. The randomization process will be conducted using a computer-based random number generator (e.g., Excel's RAND() function or tools such as random.org). This approach ensures independence and balance between groups.
Data Collection Tools Data will be collected using the Patient Identification Form, the Glasgow Coma Scale, the "Eye Care Protocol" developed by Ayfer Hiçerimez in 2024 for intensive care unit (ICU) patients, and the Schirmer Test to assess ocular dryness. Eye care interventions will be implemented based on the "Eye Care Kit Application Procedure" developed by the researcher.
- Patient Identification Form
- This form includes descriptive and clinical characteristics of the patient, such as: Age, gender, primary diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, serum albumin level.
- It also includes ocular risk factors, such as: Absence or reduction of blink reflex, ocular exposure due to incomplete eyelid closure, requirement for invasive mechanical ventilation, positive end-expiratory pressure (PEEP) level, endotracheal suctioning, tightly secured endotracheal tube, use of sedation, use of specific medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and overall patient positioning, presence of respiratory tract infections.
- Eye Care Protocol The Eye Care Protocol, developed by Ayfer Hiçerimez in 2024 for ICU patients, was designed to evaluate the effectiveness of systematic eye care and includes comprehensive assessment and care of both eyes.
- The first section of the protocol includes the patient's demographic and clinical characteristics, such as: age, gender, diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, and serum albumin levels.
- The second section addresses ocular risk factors, including: absence or reduction of the blink reflex, ocular exposure due to incomplete eyelid closure, need for invasive mechanical ventilation, level of positive end-expiratory pressure (PEEP), endotracheal suctioning, tightly secured endotracheal tube, use of sedation, use of medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and general patient positioning, and the presence of respiratory tract infections.
- The third section focuses on eye care management procedures, including:
- Hand hygiene
- Elevating the head of the bed to 30-45 degrees unless contraindicated
- Implementing infection control precautions
- Performing eye care four times daily using sterile water
- Assessing the tightness of the endotracheal tube during each eye care session
- Ensuring that the eyes of intubated patients are closed during suctioning
- Using separate sterile materials for each eye to prevent cross-infection
- Assessing and documenting ocular changes (e.g., redness, secretions, crusting at the eyelid margins, eyelash adhesion, discoloration of the conjunctiva, periorbital and conjunctival edema), and informing the ICU physician as needed
- The fourth section outlines the signs and symptoms of eye infection, including: redness, discharge, crusting of the eyelid margins, eyelash adhesion, discoloration or opacity of the cornea, and periorbital edema.
- The fifth section addresses ocular complications, specifically conjunctival edema, that may be observed in ICU patients.
- Dry Eye Monitoring Form The Schirmer Test is used to evaluate dry eye by utilizing thin filter paper strips measuring 5 mm × 30 mm. Each strip is folded at a 90° angle at one end. The bent end of the test strip is placed into the lower conjunctival sac of the eye, and left in place for 5 minutes. After 5 minutes, the strips are removed and the length of the moistened area is measured in millimeters. If the wetted portion exceeds 10 mm, tear production is considered normal. If the moist area measures less than 5 mm, it is indicative of Dry Eye Syndrome. Measurements must be taken separately for each eye.
- Eye Care Kit Application Procedure The Eye Care Kit was developed by the researchers and includes: two sterile gauze pads (one for each eye), a single-use 10 ml ampoule of distilled water, a 10 ml syringe, and an eye care pad. Two versions of the kit were prepared: one including a sterile eye occlusion pad, and one excluding it. This distinction was made to prevent unnecessary waste in patients who do not require eye occlusion. The kit content and procedure were developed with input from nine experts, and the form was revised accordingly based on their feedback.
- Standard Eye Care Record Form This form will be used to document the standard eye care provided in the intensive care unit where the study will be conducted. On each day that care is provided, the responsible nurse will complete the form, and the patient will be monitored for a total of ten days. The form was developed based on feedback from nine experts, and necessary revisions were made accordingly.
- Eye Care Monitoring Form This form will be used to collect data for both the standard eye care group and the eye care kit group.
- It includes the patient's demographic and clinical characteristics, such as: Age, gender, diagnosis, comorbidities, Glasgow Coma Scale (GCS) score, use and type of sedatives and muscle relaxants, use and type of antibiotics, duration and mode of mechanical ventilation, ambient humidity level, blink frequency per minute, degree of lagophthalmos, and serum albumin level.
- It also records ocular risk factors, including: Absence or reduction of the blink reflex, ocular exposure due to incomplete eyelid closure, need for invasive mechanical ventilation, positive end-expiratory pressure (PEEP) value, endotracheal suctioning, tightly secured endotracheal tube, use of sedation, medications (e.g., antihistamines, corticosteroids, immunosuppressive therapies, atropine), prone positioning and overall body position, and presence of respiratory tract infections.
- The monitoring of signs and symptoms of eye infection including redness, discharge, crusting on the eyelid margins, eyelash adhesion, changes in corneal color or loss of corneal transparency, and periorbital edema,
- The assessment of conjunctival edema,
- The follow-up of dry eye.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Control Group: Standard Eye Care Group | Experimental | Other: Control Group: Standard Eye Care GroupThere is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored. |
| Intervention Group 1: Eye Care Using an Eye Care Kit | Experimental | Other: Intervention Group 1: Eye Care Using an Eye Care KitEye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked. |
| Intervention Group 2: Eye Care According to an Eye Care Protocol | Experimental | Other: Intervention Group 2: Eye Care According to an Eye Care ProtocolAll ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol. Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol. Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary. In cases of incomplete eyelid closure, eyes will be covered upon physician notification. Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form. The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented. |
| Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit | Experimental | Other: Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care KitICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care. Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol. Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol. In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge. Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form. The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded. |
Who may qualify
- Ages
- 18 days and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Age 18 years or older
- Receiving mechanical ventilation
- Glasgow Coma Scale (GCS) score < 12
- At least 24 hours have passed since ICU admission
- Baseline Schirmer test result indicating tear production > 5 mm prior to study inclusion
Key exclusion criteria (8 listed)
- Diagnosed with brain death
- Presence of facial or ocular trauma
- Patients with head trauma
- Patients who have undergone brain surgery
- Patients diagnosed with an eye infection or chemosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Control Group: Standard Eye Care GroupThere is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored. | Other | Control Group: Standard Eye Care Group |
| Intervention Group 1: Eye Care Using an Eye Care KitEye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked. | Other | Intervention Group 1: Eye Care Using an Eye Care Kit |
| Intervention Group 2: Eye Care According to an Eye Care Protocol* All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol. * Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol. * Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary. * In cases of incomplete eyelid closure, eyes will be covered upon physician notification. * Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form. * The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented. | Other | Intervention Group 2: Eye Care According to an Eye Care Protocol |
| Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit* ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care. * Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol. * Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol. * In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge. * Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form. * The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded. | Other | Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit |
Primary outcome
Conjunctival Edema in Critically Ill Patients
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Conjunctival Edema (Chemosis): Chemosis is the edema of the conjunctiva, which is a thin, transparent membrane covering the inner surface of the eyelids and the white part of the eyes (sclera). It refers to the swelling of this membrane that lines the ocular surface.
Ocular Infections in Critically Ill Patients
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Signs and Symptoms of Ocular Infection: Redness, ocular discharge, crusting along the eyelid margins, adhesion of eyelashes (eyelashes sticking together), corneal discoloration (loss of corneal transparency), periorbital edema.
Dry Eye in Critically Ill Patients
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Dry Eye: Dry eye is a multifactorial disease of the ocular surface, defined by tear film instability and associated with symptoms including ocular discomfort, burning sensation, irritation, dryness, visual blurring, and foreign body sensation."
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2026.
- Individual participant dataSharing planned: Yes. Individual participant data (IPD) that underlie the results reported in publications derived from this study will be made available to qualified researchers. Shared data will include de-identified datasets and related data dictionaries.
Related trials for Eye Care
RecruitingObservational study
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
Age-related Macular Degeneration (AMD)
RecruitingPhase 2
A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy
Breast Cancer, Breast Cancer Female
RecruitingObservational study
Effect of Ketamine on Optic Nerve Sheath Diameter During Procedural Analgesia
Procedural Pain, Procedural Sedation and Analgesia
Recruiting
Effectiveness of Virtual Reality in Improving Upper Limb Function in Critically Ill Patients
Intensive Care Unit (ICU) Acquired Weakness (ICU - AW), Critical Illness
RecruitingPhase 4
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Cataract, Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Yildiz Deniz principal investigator
University of Health Sciences (Sağlık Bilimleri Üniversitesi)
Besey Oren study director
University of Health Sciences (Sağlık Bilimleri Üniversitesi)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention Group 1: Eye Care Using an Eye Care Kit, Intervention Group 2: Eye Care According to an Eye Care Protocol and Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit in people with Eye Care and Nursing Care, run by Istanbul Saglik Bilimleri University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yildiz Deniz (+905387251394, yildizdeniz142@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Conjunctival Edema in Critically Ill Patients (time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.